Organization · 2 published briefs

Merck

Every Citelink brief about Merck, newest first. Each cleared grounding and links to its sources.

Illustrative stock photo: hospital lobby reception with signage

Health

Moderna and Merck advance personalized mRNA cancer vaccine following trial success

The successful late-stage trial data for intismeran autogene marks a milestone for personalized mRNA cancer vaccines, shifting the field from decades of failure toward new combination therapies for solid tumors.

AI · grounded7 of 8 claims single-sourced

Oct 26, 202611 sources1 min read

Health

Melanoma patient shares clinical trial journey as drugmakers prepare approval filings

Patient experiences highlight the personal impact of advancing mRNA cancer therapies and point to broader industry efforts to expand targeted treatments.

AI · grounded4 of 6 claims single-sourced

Oct 24, 20268 sources1 min read

Merck

More briefs

Moderna and Merck advance personalized mRNA cancer vaccine following trial success

Melanoma patient shares clinical trial journey as drugmakers prepare approval filings